TP53 and Myelodysplasia: We examined sensitivity to GSPT1 degradation in a panel of isogenic leukemia cell lines with endogenous expression of WT or mutant TP53 alleles, including the most common TP53 mutations in high-risk myelodysplasia/AML (25).